NEW technologies for meeting the global demand for pandemic influenza vaccines
- 30 November 2008
- journal article
- Published by Elsevier BV in Biologicals
- Vol. 36 (6), 346-349
- https://doi.org/10.1016/j.biologicals.2008.07.001
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Update on Avian Influenza A (H5N1) Virus Infection in HumansThe New England Journal of Medicine, 2008
- Influenza Viruses: Basic Biology and Potential Drug TargetsInfectious Disorders - Drug Targets, 2007
- New Approaches to Confronting an Imminent Influenza PandemicThe Permanente Journal, 2007
- Commentary: From Scarcity to Abundance: Pandemic Vaccines and Other Agents for “Have Not” CountriesJournal of Public Health Policy, 2007
- Avian Influenza Virus (H5N1): a Threat to Human HealthClinical Microbiology Reviews, 2007
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Vaccine Development for an Imminent Pandemic: Why We Should Worry, What We Must DoHuman Vaccines, 2006